Letter

MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.

N. Engl. J. Med.. 2015 Aug 6;373(6):584-6.
Article

Rituximab and ibrutinib in the treatment of Waldenström's macroglobulinemia.

Future Oncol. 2019 Aug 1; 15 (23): 2687-2697.
Case Reports

Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.

J Med Case Rep. 2018 Jun 12; 12 (1): 164.